US$ 29.13
why hasn't there been more studies of bpc-157 and the Difference Between an Evidence Gap and a Cover-Up: What the entire human evidence base actually looks like, and the questions to ask next. — WellFounded The Truth About BPC 157
Description
BPC-157 is one of those areas where the preclinical data is compelling, but the human evidence just is not there yet, which makes self-experimentation tricky to interpret

The two peptides have complementary mechanisms of action, and preclinical studies suggest potentially additive healing effects across musculoskeletal and connective tissue models

The KLOW blend is a research-peptide blend containing KPV, BPC-157, GHK-Cu, and TB-500

Pentadecapeptide BPC 157 Resolves Suprahepatic Occlusion of the Inferior Cavalvein, Budd-Chiari Syndrome Model in Rats

M.ShresthaE.PeifferL

Damaged tendons and ligaments have a low level of vascularity, i.e., they get minimal blood supply and take a long time to heal
